AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 10:55 AM BST
8,411.00quote price arrow down-4.00 (-0.05%)
52 week range
6,499.80 - 10,120.00

...

Loading . . .
  • Open8,380.00
  • Day High8,414.00
  • Day Low8,354.00
  • Prev Close8,415.00
  • 52 Week High10,120.00
  • 52 Week High Date07/20/20
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21

Key Stats

  • Market Cap152,227.23M
  • Shares Out1,312.74M
  • 10 Day Average Volume1.84M
  • Dividend216.00
  • Dividend Yield2.57%
  • Beta0.19
  • YTD % Change14.75

KEY STATS

  • Open8,380.00
  • Day High8,414.00
  • Day Low8,354.00
  • Prev Close8,415.00
  • 52 Week High10,120.00
  • 52 Week High Date07/20/20
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21
  • Market Cap152,227.23M
  • Shares Out1,312.74M
  • 10 Day Average Volume1.84M
  • Dividend216.00
  • Dividend Yield2.57%
  • Beta0.19
  • YTD % Change14.75

RATIOS/PROFITABILITY

  • EPS (TTM)220.00
  • P/E (TTM)38.23
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/25/2021
  • Div Amount137.40
  • Split Date-
  • Split Factor-

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Marc Dunoyer
Chief Financial Officer
Ruud Dobber Ph.D.
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom